PortalPublikationenHacking the brain dimensions of cognitive enhancement

Hacking the brain dimensions of cognitive enhancement

Standard

Hacking the brain dimensions of cognitive enhancement. / Dresler, Martin; Sandberg, Anders; Bublitz, Christoph; Ohla, Kathrin; Trenado, Carlos; Mroczko-Wąsowicz, Aleksandra; Kühn, Simone; Repantis, Dimitris.

in: ACS CHEM NEUROSCI, Jahrgang 10, Nr. 3, 20.03.2019, S. 1137-1148.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Dresler, M, Sandberg, A, Bublitz, C, Ohla, K, Trenado, C, Mroczko-Wąsowicz, A, Kühn, S & Repantis, D 2019, 'Hacking the brain dimensions of cognitive enhancement', ACS CHEM NEUROSCI, Jg. 10, Nr. 3, S. 1137-1148. https://doi.org/10.1021/acschemneuro.8b00571

APA

Dresler, M., Sandberg, A., Bublitz, C., Ohla, K., Trenado, C., Mroczko-Wąsowicz, A., Kühn, S., & Repantis, D. (2019). Hacking the brain dimensions of cognitive enhancement. ACS CHEM NEUROSCI, 10(3), 1137-1148. https://doi.org/10.1021/acschemneuro.8b00571

Vancouver

Dresler M, Sandberg A, Bublitz C, Ohla K, Trenado C, Mroczko-Wąsowicz A et al. Hacking the brain dimensions of cognitive enhancement. ACS CHEM NEUROSCI. 2019 Mär 20;10(3):1137-1148. https://doi.org/10.1021/acschemneuro.8b00571

Bibtex

@article{d600eedaf4a5429fb1d48a14adb91ba0,
title = "Hacking the brain dimensions of cognitive enhancement",
abstract = "In an increasingly complex information society, demands for cognitive functioning are growing steadily. In recent years, numerous strategies to augment brain function have been proposed. Evidence for their efficacy (or lack thereof) and side effects has prompted discussions about ethical, societal and medical implications. In the public debate, cognitive enhancement is often seen as a monolithic phenomenon. On a closer look, however, cognitive enhancement turns out to be a multifaceted concept: There is not one cognitive enhancer that augments brain function per se, but a great variety of interventions that can be clustered into biochemical, physical and behavioral enhancement strategies. These cognitive enhancers differ in their mode of action, the cognitive domain they target, the timescale they work on, their availability and side effects, and how they differentially affect different groups of subjects. Here we disentangle the dimensions of cognitive enhancement, review prominent examples of cognitive enhancers that differ across these dimensions, and thereby provide a framework for both theoretical discussions and empirical research.",
keywords = "Journal Article, Brain/drug effects, Animals, Nootropic Agents/pharmacology, Humans, Cognition/physiology, Cognitive Behavioral Therapy/methods, Transcranial Magnetic Stimulation/methods",
author = "Martin Dresler and Anders Sandberg and Christoph Bublitz and Kathrin Ohla and Carlos Trenado and Aleksandra Mroczko-W{\c a}sowicz and Simone K{\"u}hn and Dimitris Repantis",
year = "2019",
month = mar,
day = "20",
doi = "10.1021/acschemneuro.8b00571",
language = "English",
volume = "10",
pages = "1137--1148",
journal = "ACS CHEM NEUROSCI",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "3",

}

RIS

TY - JOUR

T1 - Hacking the brain dimensions of cognitive enhancement

AU - Dresler, Martin

AU - Sandberg, Anders

AU - Bublitz, Christoph

AU - Ohla, Kathrin

AU - Trenado, Carlos

AU - Mroczko-Wąsowicz, Aleksandra

AU - Kühn, Simone

AU - Repantis, Dimitris

PY - 2019/3/20

Y1 - 2019/3/20

N2 - In an increasingly complex information society, demands for cognitive functioning are growing steadily. In recent years, numerous strategies to augment brain function have been proposed. Evidence for their efficacy (or lack thereof) and side effects has prompted discussions about ethical, societal and medical implications. In the public debate, cognitive enhancement is often seen as a monolithic phenomenon. On a closer look, however, cognitive enhancement turns out to be a multifaceted concept: There is not one cognitive enhancer that augments brain function per se, but a great variety of interventions that can be clustered into biochemical, physical and behavioral enhancement strategies. These cognitive enhancers differ in their mode of action, the cognitive domain they target, the timescale they work on, their availability and side effects, and how they differentially affect different groups of subjects. Here we disentangle the dimensions of cognitive enhancement, review prominent examples of cognitive enhancers that differ across these dimensions, and thereby provide a framework for both theoretical discussions and empirical research.

AB - In an increasingly complex information society, demands for cognitive functioning are growing steadily. In recent years, numerous strategies to augment brain function have been proposed. Evidence for their efficacy (or lack thereof) and side effects has prompted discussions about ethical, societal and medical implications. In the public debate, cognitive enhancement is often seen as a monolithic phenomenon. On a closer look, however, cognitive enhancement turns out to be a multifaceted concept: There is not one cognitive enhancer that augments brain function per se, but a great variety of interventions that can be clustered into biochemical, physical and behavioral enhancement strategies. These cognitive enhancers differ in their mode of action, the cognitive domain they target, the timescale they work on, their availability and side effects, and how they differentially affect different groups of subjects. Here we disentangle the dimensions of cognitive enhancement, review prominent examples of cognitive enhancers that differ across these dimensions, and thereby provide a framework for both theoretical discussions and empirical research.

KW - Journal Article

KW - Brain/drug effects

KW - Animals

KW - Nootropic Agents/pharmacology

KW - Humans

KW - Cognition/physiology

KW - Cognitive Behavioral Therapy/methods

KW - Transcranial Magnetic Stimulation/methods

U2 - 10.1021/acschemneuro.8b00571

DO - 10.1021/acschemneuro.8b00571

M3 - SCORING: Review article

C2 - 30550256

VL - 10

SP - 1137

EP - 1148

JO - ACS CHEM NEUROSCI

JF - ACS CHEM NEUROSCI

SN - 1948-7193

IS - 3

ER -